This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Secretary of. Active years: 1987.
Company Filing History:
Years Active: 1987
Title: The Innovations of Peter Lelkes
Introduction
Peter Lelkes is an accomplished inventor based in Rockville, MD (US). He has made significant contributions to the field of biomedical research, particularly in the area of blood clotting factors. His work has the potential to impact the treatment of hemophilia, a condition that affects many individuals worldwide.
Latest Patents
Peter Lelkes holds a patent for the "Isolation and culture of adrenal medullary endothelial cells producing Factor VIII:C." This invention discloses a new line of endothelial cells of adrenal medullary origin that are capable of producing blood clotting Factor VIII:C. The method of isolating and culturing this cell line has also been detailed in the patent. Factor VIII:C is crucial for treating hemophilia, making this invention particularly valuable.
Career Highlights
Lelkes has dedicated his career to advancing medical science through innovative research. His patent reflects his commitment to finding solutions for complex health issues. He works for the United States of America as Represented by the Secretary of Health and Human Services, where he continues to contribute to the field.
Collaborations
Throughout his career, Peter has collaborated with notable colleagues, including Harvey B Pollard and Richard Ornberg. These partnerships have fostered a collaborative environment that enhances the research and development of new medical technologies.
Conclusion
Peter Lelkes is a notable inventor whose work in isolating and culturing endothelial cells has the potential to transform treatments for hemophilia. His contributions to biomedical research exemplify the importance of innovation in healthcare.